SE7713896L - Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler - Google Patents

Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler

Info

Publication number
SE7713896L
SE7713896L SE7713896A SE7713896A SE7713896L SE 7713896 L SE7713896 L SE 7713896L SE 7713896 A SE7713896 A SE 7713896A SE 7713896 A SE7713896 A SE 7713896A SE 7713896 L SE7713896 L SE 7713896L
Authority
SE
Sweden
Prior art keywords
ostren
16alfa
15alfa
oler
17beta
Prior art date
Application number
SE7713896A
Other languages
English (en)
Other versions
SE426834B (sv
Inventor
R Wiechert
H Steinbeck
W Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7713896L publication Critical patent/SE7713896L/sv
Publication of SE426834B publication Critical patent/SE426834B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7713896A 1972-02-11 1977-12-07 Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler SE426834B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
SE7713896L true SE7713896L (sv) 1977-12-07
SE426834B SE426834B (sv) 1983-02-14

Family

ID=5836211

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7301935A SE403781B (sv) 1972-02-11 1973-02-12 Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-oler
SE7514513A SE409329B (sv) 1972-02-11 1975-12-22 15 alfa, 16 alfa-metylen-4-ostren-17 beta-oler till anvendning som kontraceptionsmedel
SE7713896A SE426834B (sv) 1972-02-11 1977-12-07 Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7301935A SE403781B (sv) 1972-02-11 1973-02-12 Sett att framstella 15 alfa, 16 alfa-metylen-4-ostren- 17 beta-oler
SE7514513A SE409329B (sv) 1972-02-11 1975-12-22 15 alfa, 16 alfa-metylen-4-ostren-17 beta-oler till anvendning som kontraceptionsmedel

Country Status (29)

Country Link
JP (1) JPS5829317B2 (sv)
KR (1) KR780000156B1 (sv)
AT (1) AT327413B (sv)
AU (1) AU467306B2 (sv)
BE (1) BE795241A (sv)
CA (1) CA997753A (sv)
CH (2) CH593995A5 (sv)
CS (1) CS193019B2 (sv)
DD (1) DD102379A5 (sv)
DE (1) DE2207421C3 (sv)
DK (1) DK131037B (sv)
EG (1) EG10914A (sv)
ES (1) ES410933A1 (sv)
FI (1) FI52225C (sv)
FR (1) FR2181719B1 (sv)
GB (1) GB1425636A (sv)
GR (1) GR63160B (sv)
HU (1) HU165253B (sv)
IE (1) IE37266B1 (sv)
IL (1) IL41506A (sv)
NL (1) NL177217C (sv)
NO (2) NO140304C (sv)
PH (1) PH9370A (sv)
PL (1) PL81084B1 (sv)
RO (1) RO73527A (sv)
SE (3) SE403781B (sv)
SU (1) SU513628A3 (sv)
YU (1) YU35035B (sv)
ZA (1) ZA73944B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
CH590883A5 (sv) 1977-08-31
GB1425636A (en) 1976-02-18
FR2181719B1 (sv) 1975-11-21
HU165253B (sv) 1974-07-27
IE37266L (en) 1973-08-11
RO73527A (ro) 1982-02-01
IL41506A0 (en) 1973-04-30
CH593995A5 (sv) 1977-12-30
IL41506A (en) 1976-07-30
AU467306B2 (en) 1975-11-27
DD102379A5 (sv) 1973-12-12
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
KR780000156B1 (en) 1978-05-02
DE2207421B2 (de) 1980-07-24
NO143065C (no) 1980-12-10
IE37266B1 (en) 1977-06-08
GR63160B (en) 1979-09-25
YU24373A (en) 1979-12-31
NO782754L (no) 1973-08-14
NL177217B (nl) 1985-03-18
YU35035B (en) 1980-06-30
EG10914A (en) 1976-09-30
FI52225C (sv) 1977-07-11
SE7514513L (sv) 1975-12-22
NL7301974A (sv) 1973-08-14
NO140304B (no) 1979-04-30
NL177217C (nl) 1985-08-16
ATA112473A (de) 1975-04-15
SE426834B (sv) 1983-02-14
SU513628A3 (ru) 1976-05-05
BE795241A (fr) 1973-08-09
AT327413B (de) 1976-01-26
ZA73944B (en) 1973-11-28
DK131037C (sv) 1975-10-20
DK131037B (da) 1975-05-20
FR2181719A1 (sv) 1973-12-07
PL81084B1 (sv) 1975-08-30
ES410933A1 (es) 1976-03-01
CA997753A (en) 1976-09-28
SE409329B (sv) 1979-08-13
JPS4886856A (sv) 1973-11-15
NO143065B (no) 1980-09-01
CS193019B2 (en) 1979-09-17
PH9370A (en) 1975-10-22
FI52225B (sv) 1977-03-31
DE2207421A1 (de) 1973-08-16
JPS5829317B2 (ja) 1983-06-22
DE2207421C3 (de) 1981-05-07
AU5207673A (en) 1974-08-15

Similar Documents

Publication Publication Date Title
BE799252A (fr) Raccord,
SE411545B (sv) Sett att framstella chalkonetrar.
NL7405486A (nl) Cultivator.
SE7504337L (sv) Sett att framstella prostansyraderivat.
SE7409233L (sv) Sett att diagnostisera dysmetrisk dyslexi.
SE399255B (sv) Sett att framstella kinazolinonderivat
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE405966B (sv) Sett att framstella peptider
SE400078B (sv) Sett att framstella kinazolinonderivat
BE799751A (nl) Ketel,
SE384208B (sv) Sett att framstella nya 2,6-diamino-dihydropyridiner
SE400281B (sv) Sett att framstella kinazolinonderivat
SE385882B (sv) Sett att framstella nya 3,4-dihydropyridoner
SE395007B (sv) Sett att framstella 9,10-seko-ostranderivat
NO143096C (no) Koronagenerator.
NL7403557A (nl) Vorminrichting.
SE7702331L (sv) Sett att framstella vinkamon
SE7713896L (sv) Sett att framstella 15alfa, 16alfa-metylen-4-ostren-17beta-oler
NL7410301A (nl) Gesubstitueerde fenylglycylcefalosporinen.
BE808336A (fr) Azabenzo-1,5-diazepines
SE405971B (sv) Sett att framstella 1,4-bensodiazepinderivat
SE392668B (sv) Sett att framstella margarin
SE390307B (sv) Sett att separera cefalosporin c
BE791629A (fr) Plaatconstructie en bevestigingssteun gebruikt bij deze plaatconstructie.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7713896-4

Effective date: 19890425

Format of ref document f/p: F